Thursday, 30 March 2017
News with tag Pfizer  RSS
Could Real-World Studies Boost These 3 Big Pharma Stocks' Prospects?

Added: 28.03.2017 22:01 | 6 views | 0 comments

AstraZeneca, Bristol-Myers Squibb, and Pfizer receive good news from the real world.

Tags: Stocks, Pfizer
From: feeds.foxbusiness.com

3 Big Pharma Stocks You Don't Have to Babysit

Added: 27.03.2017 15:02 | 6 views | 0 comments

No tending needed for big pharma stocks Johnson & Johnson, Pfizer, and Novartis.

Tags: Stocks, Pfizer
From: feeds.foxbusiness.com

3 Tremendously Promising Diabetes Drugs Potentially on the Way

Added: 26.03.2017 14:03 | 2 views | 0 comments

Diabetes patients could have new treatment options if Merck, Pfizer, Lexicon, Sanofi, and Novo Nordisk succeed with these three promising drugs.

Tags: Pfizer
From: feeds.foxbusiness.com

Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant)

Added: 25.03.2017 19:00 | 6 views | 0 comments

Valeant's debt load is huge. But it's not as great as what Pfizer and AbbVie owe.

Tags: GM, Pfizer
From: feeds.foxbusiness.com

1 Top Stock in Big Pharma

Added: 25.03.2017 10:43 | 7 views | 0 comments

Pfizer is an outstanding big pharma stock to own for the long term.

Tags: Stocks, Pfizer
From: feeds.foxbusiness.com

FDA approves Pfizer, German Merck immunotherapy for skin cancer

Added: 23.03.2017 20:11 | 5 views | 0 comments

U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body.

From: www.channelnewsasia.com

Pregabalin found ineffective against sciatic pain

Added: 22.03.2017 21:50 | 3 views | 0 comments

- Pregabalin, the pain-fighting drug better known by the Pfizer brand name Lyrica, works no better than placebo at relieving the leg pain associated with sciatica, according to results from an Australian study of more than 200 patients.

From: www.channelnewsasia.com

advertising
Liberty.edu Online

Copyright © 2008-2017 USweekly.com  - all rights reserved